Last reviewed · How we verify
Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection
Injection of OnabotulinumtoxinA (BTX-A) into the bladder is a widely used treatment option for patients with overactive bladder who have failed medical therapy. Urinary tract infection is the most common side effect of this procedure and therefore antibiotics are given around the time of injection in order to prevent these events. While antibiotics are commonly given at the time of injection, the duration of these antibiotic regimens are variable. The investigators propose a study to investigate different antibiotic protocols and their affect on the rate of urinary tract infection after injection.
Details
| Lead sponsor | Vanderbilt University Medical Center |
|---|---|
| Phase | PHASE4 |
| Status | TERMINATED |
| Enrolment | 22 |
| Start date | Sun Jul 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Jun 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Overactive Bladder
- Urinary Tract Infections
Interventions
- Periprocedural Antibiotics
- Extended Antibiotics
- Injection of OnabotulinumtoxinA (BTX-A)
Countries
United States